Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company (4016.SR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · 4016.SR · as of Jun 15, 2026
Key Statistics
Explore Middle East Pharmaceutical Industries Company Data
4016.sr stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
4016.sr competitors4016.SR
2070.SR
4009.SR
4014.SR
4163.SR
9518.SRStock Performance
Full HistoryAbout Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company (MEPIC), established in Riyadh, Saudi Arabia, in 1998, is a global pharmaceutical entity. The company's core activities encompass the entire lifecycle of …
what is middle east pharmaceutical industries company · 4016.sr stock overview · middle east pharmaceutical industries company company profile · who is middle east pharmaceutical industries company ceo · 4016.sr SAU · middle east pharmaceutical industries company headquarters · middle east pharmaceutical industries company business segments
About Stock Overview & Key Data
Middle East Pharmaceutical Industries Company (4016.SR) is a Healthcare company in the Medical - Pharmaceuticals industry, listed on SAU since Feb 27, 2024. As of the latest trading session, 4016.SR stock price is $62.10, with a market capitalization of $2.2B. The stock has returned -7.27% over the past 12 months and -2.27% year-to-date.
In fiscal year 2025, Middle East Pharmaceutical Industries Company reported revenue of $460.5M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Middle East Pharmaceutical Industries Company (4016.SR) stock price is $62.10. The stock is traded on SAU under the ticker symbol 4016.SR. The 52-week range is $53.89 – $79.09.